Overview

A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

Status:
COMPLETED
Trial end date:
2024-07-10
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial to determine the safety and effectiveness of treating the COPD symptoms with subcutaneous BOTOX injections in participants with moderate COPD.
Phase:
PHASE2
Details
Lead Sponsor:
RMW Testing
Treatments:
Botulinum Toxins, Type A